Live Breaking News & Updates on Tasmina Hydery

Stay updated with breaking news from Tasmina hydery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Expert Discusses Cost Savings Through Biosimilars

Tasmina Hydery, PharmD, BCGP, discusses how stakeholders can work together to generate and share real-world evidence on biosimilar effectiveness and switching in order to drive adoption and realize cost savings potential. ....

United States , Tasmina Hydery , Cencora Managed Care Network , Managed Care Network ,

Payer Coverage of Biosimilars Always Shifting, Says Dr Tasmina Hydery

Payer coverage of biosimilars is always shifting as new ones come to market, explained Tasmina Hydery, PharmD, MBA, BCGP, associate director in digital solutions, Cencora. ....

United States , Las Vegas , Gillian Woollett , Samsung Bioepis , Tasmina Hydery , Joseph Park , Oncology Practice Network , Biosimilars Collective Intelligence Consortium , Health Systems , Pharmacy Practice , Asembia Specialty Pharmacy Summit , Lakesha Farmer , Practice Network , Cate Lockhart , Biosimilars Collective Intelligence , Payer Coverage ,

Top 5 Content From Asembia 2023

The most popular content from our Asembia coverage largely covered biosimilars. ....

United States , Bansi Nagji , Pierre Theodore , Preeti Parikh , Ray Tancredi , Las Vegas , Julie Reed , Tasmina Hydery , Juliana Julie Reed , How Are Health Care Organizations , Biosimilars Forum , Biosimilars Collective Intelligence Consortium , While Asembia , Epharmacy Summit , American Journal , Are Health Care Organizations Working , Status Quo , Biosimilars Needs , Specialty Therapy Pipeline , Shows Payers More Likely , Prefer Multiple Biosimilars , Same Reference , Cate Lockhart , Biosimilars Collective Intelligence ,

Asembia: Payers More Likely to Prefer Multiple Biosimilars for the Same Reference Product

In a panel at the 2023 Asembia Specialty Pharmacy Summit, speakers presented on the payer perspective regarding biosimilars, including that they feel comfortable preferring multiple biosimilars for the same reference product and are looking for interchangeability designations. ....

United States , Tasmina Hydery , Las Vegas , Biosimilars Collective Intelligence Consortium , Specialty Pharmacy Summit , Biosimilars Be Larger , Payer Response , Inflation Reduction Act ,

Survey Shows Payers More Likely to Prefer Multiple Biosimilars for the Same Reference Product

In a panel at the 2023 Asembia Specialty Pharmacy Summit, speakers presented on the payer perspective regarding biosimilars, including that they feel comfortable preferring multiple biosimilars for the same reference product and are looking for interchangeability designations. ....

United States , Tasmina Hydery , Las Vegas , Biosimilars Collective Intelligence Consortium , Specialty Pharmacy Summit , Biosimilars Be Larger , Payer Response , Inflation Reduction Act , Payer Preferences ,